Granzyme B, a serine protease derived from cytotoxic T lymphocyte (CTL) and Natural Killer (NK) cell granules, plays an important role in coordinating apoptosis of CTL and NK target cells. Here, we report that granzyme B targets the cytoskeleton by cleaving and removing the acidic C-terminal tail of ␣-tubulin. Consistent with this, Granzyme B markedly enhanced rates of microtubule polymerization in vitro, most likely by removal of an autoinhibitory domain within the tubulin C terminus. Moreover, delivery of Granzyme B into HeLa target cells promoted dramatic reorganization of the microtubule network in a caspase-independent manner. These data reveal that granzyme B directly attacks a major component of the cell cytoskeleton, which may contribute to the incapacitation of target cells during CTL/NK-mediated killing.
Granzyme B, a serine protease derived from cytotoxic T lymphocyte (CTL) and Natural Killer (NK) cell granules, plays an important role in coordinating apoptosis of CTL and NK target cells. Here, we report that granzyme B targets the cytoskeleton by cleaving and removing the acidic C-terminal tail of ␣-tubulin. Consistent with this, Granzyme B markedly enhanced rates of microtubule polymerization in vitro, most likely by removal of an autoinhibitory domain within the tubulin C terminus. Moreover, delivery of Granzyme B into HeLa target cells promoted dramatic reorganization of the microtubule network in a caspase-independent manner. These data reveal that granzyme B directly attacks a major component of the cell cytoskeleton, which may contribute to the incapacitation of target cells during CTL/NK-mediated killing.
Cytotoxic T lymphocytes (CTL) 2 and Natural Killer (NK) cells play an important role in anti-viral and anti-tumor immunity by triggering apoptosis in infected or transformed target cells (1, 2) . CTL/NK cells also play an important role in the attack of transplanted tissue during graft versus host disease (3) . Understanding the molecular basis of CTL/NK killing is likely to reveal proteins that are important for the maintenance of cell viability and/or proliferative potential or, conversely, that act as important mediators of cell death.
One way in which CTL/NK cells induce apoptosis of their targets is by exocytosis of specialized secretory granules, known as cytotoxic lymphocyte (CL) granules, in the vicinity of target cells (2, 4) . The key constituents of CL granules are perforin, a pore-forming protein, and the granzymes (Gzm), a family of closely related cytotoxic serine proteases (5-7). Humans possess five granzymes exhibiting distinct enzymatic activities, although some of these enzymes await full characterization as substrates for some of the granzymes remain to be identified (7) (8) (9) .
At present, GzmA and GzmB are the most highly characterized granule proteases as the proteolytic specificity of these enzymes has been elucidated and some substrates have been identified (2, 10 -12) . Whereas GzmA is a tryptase, GzmB shares with the caspase family of proteases a preference for aspartate residues in the P1 position of its substrates (10, 13) . In addition, GzmB possesses an extended substrate specificity, determined by the recognition of P1Ј and P2Ј amino acid residues at the C terminus of the proteolytic cleavage site (10, 13) . This extended specificity may explain, in part, the fact that although several hundred substrates have been identified for executioner caspases only a handful of GzmB targets have thus far been identified (14) .
Current knowledge suggests that GzmB can induce apoptosis of target cells in two mechanistically distinct ways. GzmB can directly process caspases-3, -7, -8, and -10, thereby directly activating the cell death machinery (15, 16) . In addition, human GzmB can cleave the small BH-3-only protein Bid (17) . Proteolysis of Bid enhances its ability to translocate to mitochondria and trigger the opening of cytochrome c-releasing channels comprised of Bax and/or Bak oligomers (18) . These two GzmB-initiated pathways converge at the point of engaging caspasedependent cell death. However, several studies have shown that GzmB can kill target cells even in the presence of caspase inhibitors (19 -21) . This suggests that caspase-independent pathways regulated by GmzB may exist and predicts that as yet unidentified GzmB substrates may participate in caspase-independent killing (16, 19 -21) .
To further elucidate the mechanism of GzmB-dependent killing, we and others have undertaken screens to search for novel targets of this protease (12, 16) . Here, using a proteomics-based approach, we have identified ␣-tubulin as a GzmB substrate. ␣-Tubulin represents a highly sensitive target of GzmB as this major microtubule component is cleaved at concentrations of GzmB that fail to cleave caspase-3. GmzBmediated proteolysis of purified ␣-tubulin dramatically enhanced the ability of the latter to assemble into microtubules, as assessed by in vitro polymerization assays. Moreover, delivery of GzmB into target cells resulted in an altered microtubule morphology characterized by increased microtubule length and diameter. Thus, targeting of microtubules by GzmB represents a novel biological end point for CTL/NKmediated apoptosis. GzmB-mediated perturbation of microtubule networks during CTL/NK attack may contribute to disabling target cell function. cells as previously described (22) . For in vitro Granzyme-B-mediated activation of caspases, aliquots of cell-free extract were diluted 2-fold in cell extract buffer supplemented with a final concentration of 100 nM purified human granzyme-B and 5 M Z-VAD-fmk. Alternatively, to trigger apoptosome-dependent caspase activation, bovine heart cytochrome c and dATP were added to parallel reactions to final concentrations of 50 g/ml and 1 mM, respectively. Two-dimensional Gel Electrophoresis and MALDI-TOF Mass Spectrometry-For proteomic analysis, cell-free extracts were analyzed by isoelectric focusing (350 g/gel) and two-dimensional electrophoresis as previously described (23) . Candidate protein spots were excised, trypsin-digested, and analyzed in positive reflectron mode in a Voyager DE Pro MALDI mass spectrometer (Applied Biosciences). After applying a filter to remove common background contaminant peaks, the de-isotoped spectra were submitted to the MS-Fit and MASCOT webbased databases for protein identification.
Coupled in Vitro Transcription and Translation-35 S-labeled proteins were generated using the TNT kit (Promega) as described previously (22) .
Microtubule Polymerization Assays-Microtubule polymerization assays utilized purified bovine tubulin purchased from Cytoskeleton Inc. To determine the effects of GzmB on microtubule polymerization rates, bovine tubulin was solubilized in polymerization buffer (80 mM piperazine-N,NЈ-bis[2-ethanesulfonic acid] sequisodium salt, 2 mM MgCl 2 , 0.5 mM ethylene glycol-bis (b-amino-ethyl ether) N,N,NЈ,NЈ-tetra-acetic acid, pH 6.9, containing 5% (v/v) glycerol) at a final concentration of 3 mg/ml. Following incubation with GzmB for 40 min at 30°C, polymerization of microtubules was stimulated by the addition of 1 mM guanosine 5Ј-triphosphate (GTP). Change in microtubule turbidity was monitored at 340 nm in an automated fluorimeter at 37°C (Tecan).
Loading of GzmB and Detection of Microtubule Morphology by Immunostaining-HeLa cells were plated on coverslips at a density of 2.0 ϫ 10 5 cells/well in 6-well plates. 24 h later, cells were loaded with GzmB using sublytic doses of the pore-forming protein streptolysin-O (SLO). Briefly, an aliquot of SLO was pre-activated by incubating for 30 min at room temperature in phosphate-buffered saline containing 1 mM dithiothreitol. Cells were then washed in serum-free medium, followed by drop-wise addition of 110 l of RPMI containing 6.5 M dithiothre- itol, 2.25 g/ml of SLO, and 300 nM GzmB to the cell monolayers. Wells were flooded 30 min later with 2 ml of RPMI containing 5% fetal calf serum. Cells were cultured for a total of 7 h before fixation in phosphatebuffered saline/3% paraformaldehyde and immunostaining with anti-␣-tubulin antibodies (clone DM1A) followed by rhodamine-coupled secondary antibodies. Fluorescence images were acquired at ϫ60 and ϫ100 magnification on an Olympus UV microscope (Mason  Technology) .
siRNA-mediated Ablation of ␣-Tubulin Expression Levels and Expression of Non-cleavable ␣-Tubulin-To examine the effects of siRNA-mediated ablation of ␣-tubulin, HeLa cells were transfected with Oligofectamine according to the manufacturer's instructions. The following ␣-tubulin-specific oligos were used: Oligo 1, 5Ј-AAG TCC AAG CTG GAG TTC TCC-3Ј; Oligo 2, 5Ј-AAG GTA CAG AGA GCT GTG TGC-3Ј. As a negative control, an oligo specific to the nuclear matrix protein p84 was used: 5Ј-AAG UCC UGA UGU UCG GCG AGA-3Ј. To examine the effects of overexpression of non-cleavable ␣-tubulin, we transfected HeLa cells with Genejuice, according to the manufacturer's instructions. For apoptosis assays, HeLa cells were transfected with either siRNAs or ␣-tubulin expression plasmids for 24 h prior to exposure to pro-apoptotic stimuli or co-incubation with the NK cell line, YT.
RESULTS

Identification of ␣-Tubulin as a Novel GzmB
Target-To identify novel substrates of the CTL/NK protease GzmB, we utilized an in vitro assay in which cell-free extracts generated from Jurkat T lymphocytes were incubated with purified GzmB (16) . To eliminate proteolytic events caused by caspases activated by GzmB, we exploited the fact that the inhibitor Z-VAD-fmk potently blocks caspase activity but does not inhibit GzmB (24) . Therefore, under these conditions only GzmB-dependent changes were observed. To identify novel GzmB substrates, we incubated cell-free extracts in the presence of GzmB (100 nM) and Z-VAD-fmk and analyzed the extracts by isoelectric focusing coupled to two-dimensional gel electrophoresis (Fig. 1A ). This analysis revealed several protein spots that were consistently altered in a GzmB-dependent manner. In particular, two prominent protein spots were found to be altered upon incubation of cell-free extract in the presence of GzmB. As shown in Fig. 1A , one of these spots was a highly abundant protein present in untreated cell-free extracts that was lost upon incubation FIGURE 2. ␣-Tubulin is cleaved by GzmB in a caspase-independent manner. A, Jurkat cell-free extracts treated with either 5 M Z-VAD-fmk, 100 nM GzmB, or both were incubated at 37°C for the indicated times. Samples were resolved by SDS-PAGE and immunoblotted with the indicated antibodies. B, Jurkat cell-free extract containing 5 M Z-VAD-fmk was treated with the indicated final concentrations of GzmB and incubated for 2 h at 37°C. Samples were immunoblotted with the indicated antibodies. C, HeLa targets were incubated in the presence or absence of a 5:1 ratio of YT cells, with or without 100 M Z-VAD-fmk. YT cells were removed after 8 h and the medium replaced. After a total of 24 h, floating and adherent HeLa cells were combined and lysed. Lysates were subjected to SDS-PAGE, followed by immunoblotting with the indicated antibodies. FIGURE 3. ␣-and ␤-Tubulin are both cleaved by caspases. A, Jurkat cell-free extracts, either untreated or treated with 50 g/ml cytochrome c and 1 mM dATP, were incubated for 2 h at 37°C. Proteins (350 g/immobilized pH gradient strip) were analyzed as described for Fig. 1A . The protein spot identified as caspase-cleaved ␣-tubulin is denoted by a circle; full-length tubulin is indicated by a square. B, Jurkat cell-free extracts, treated as in panel A, were incubated at 37°C for the indicated times followed by immunoblot analysis with the indicated antibodies. C, cell-free extracts generated from MCF-7 cells that lack caspase-3 were either untreated or supplemented with 50 g/ml cytochrome c and 1 mM dATP and incubated at 37°C for the indicated times. Reactions were assessed by immunoblotting with the indicated antibodies.
with GzmB, whereas the other was a novel protein spot that appeared only in GzmB-treated samples. Both of these spots were excised from two-dimensional gels and were identified by mass spectrometry. This analysis revealed that both protein spots were ␣-tubulin (Fig. 1B) , strongly suggesting that this protein is a substrate for GzmB. These data are in agreement with a recent study that reported that murine GzmB cleaves ␣-tubulin (12) . Examination of the amino acid coverage identified by MALDI-TOF mass spectrometry of the cleaved form of ␣-tubulin revealed peptide coverage of ϳ70% of the ␣-tubulin sequence. This suggested that GzmB cleaves ␣-tubulin either within the first 20 amino acids or within the last ϳ20 amino acids of the protein (Fig. 1C) .
GzmB-mediated Proteolysis of ␣-Tubulin in Vitro-To confirm that the alterations observed by two-dimensional gel analysis represented proteolysis of ␣-tubulin (as opposed to some other post-translational modification), we performed immunoblotting experiments. To this end, we treated Jurkat cell-free extract with purified GzmB, with or without Z-VAD-fmk, and monitored the electrophoretic mobility of ␣-tubulin by immunoblotting. As the MALDI-TOF mapping suggested that GzmB potentially removed only a small fragment from ␣-tubulin, we ran 8% SDS-PAGE gels in order to detect subtle changes in the molecular weight of this protein. As shown in Fig. 2A , within 15 min of the addition of 100 nM GzmB, ␣-tubulin became truncated to a lower molecular weight form, indicative of proteolysis. Importantly, proteolysis of ␣-tubulin was directly mediated by GzmB and not by adventitious caspase activity as addition of Z-VAD-fmk to extracts failed to block ␣-tubulin cleavage ( Fig. 2A) . By contrast, Z-VAD-fmk completely blocked processing of the caspase substrate XIAP (Fig. 2A) . Interestingly, whereas ␣-tubulin was cleaved in a completely GzmB-dependent but caspase-independent manner, ␤-tubulin also appeared to be cleaved when Z-VAD-fmk was omitted from the reactions (Fig. 2A) . Thus, GzmB selectively cleaves ␣-tubulin, and ␤-tubulin might be a substrate for caspase-mediated proteolysis (see below).
␣-Tubulin Is a Preferential Target of GzmB-To examine the relative susceptibility of ␣-tubulin to GzmB-mediated proteolysis compared with other GzmB substrates, we titrated GzmB into Jurkat cell-free extract. Once again, Z-VAD-fmk was included in all reactions to inhibit caspase activity. As shown in Fig. 2B , low concentrations of GzmB (25 nM) were sufficient to induce significant cleavage of ␣-tubulin and of the well known GzmB substrate Bid (Fig. 2B) . By contrast, caspase-3 was somewhat less sensitive to GzmB-mediated cleavage under the same conditions. These data indicate that ␣-tubulin is cleaved by GzmB at concentrations of this granzyme that are comparable with those required to cleave Bid.
GzmB-mediated Proteolysis of ␣-Tubulin during NK/GzmB-dependent Attack of Target Cells-Because some proteins are cleaved by GzmB in vitro but not in vivo, we next assessed whether proteolysis of ␣-tubulin occurred within the context of NK-mediated attack. To explore this, we exposed HeLa target cells to the NK cell line YT in the presence or the absence of the caspase inhibitor Z-VAD-fmk. Consistent with previous reports, NK killing was comprised of caspase-dependent as well as caspase-independent components (19 -21) . Thus, the caspase inhibitor Z-VAD-fmk afforded only partial protection to HeLa cells from NK attack (Fig. 2C) . Lysates generated from the apoptotic HeLa targets were then immunoblotted with tubulin-specific antibodies. As shown in Fig.  2C , ␣-tubulin was completely cleaved in the HeLa targets even when caspases were inhibited. By contrast, loss of the full-length form of ␤-tubulin was blocked in the presence of Z-VAD-fmk, again suggesting that ␤-tubulin may be cleaved by caspases but not directly by GzmB. These data show that NK killing instigates direct proteolysis of ␣-tubulin, most likely via GzmB.
Caspases Cleave ␣-and ␤-Tubulin-Most, if not all, of the currently identified GzmB substrates are also substrates of executioner caspases. We therefore asked whether microtubules are also targeted by caspases during apoptosis. Similar proteomic-based experiments using Jurkat cell-free extracts in which caspases were activated using cytochrome c and dATP (to initiate assembly of the Apaf-1 apoptosome) identified the same ␣-tubulin proteolytic fragment that was detected in GzmBtreated cell-free extracts (Fig. 3A) . To confirm ␣-tubulin proteolysis by caspases, we also Western blotted cell-free extracts that had been incubated in the presence or absence of cytochrome c/dATP (22) . As shown in Fig. 3B , a truncated form of ␣-tubulin similar to the GzmB-cleaved form was observed, although this fragment appeared with slower kinetics than observed with GzmB ( Fig. 2A) . In addition, ␤-tubulin was found to be cleaved under these conditions, as indicated by loss of the fulllength form of the protein (Fig. 3B) . Thus, although GzmB selectively targets only one half of the tubulin dimer, caspases appear to cleave both isoforms of tubulin. Interestingly, neither form of tubulin was cleaved in parallel experiments using extracts generated from MCF-7 cells, which lack caspase-3 ( Fig. 3C ). These data suggest that caspase-3, or a protease activated downstream of caspase-3, is responsible for cleavage of both ␣-and ␤-tubulin.
GzmB Cleavage of ␣-Tubulin at a Canonical Site Removes the C-terminal Acidic Tail
Motif-We then sought to map the cleavage site for GzmB within ␣-tubulin. As GzmB exhibits a near absolute preference for Asp residues in the P1 position, we scanned the ␣-tubulin amino acid sequence for possible GzmB cleavage motifs. Inspection of the ␣-tubulin amino acid sequence identified only three candidate Asp residues in the areas outside the MALDI-TOF peptide mass fingerprint coverage, suggesting that GzmB cleaves ␣-tubulin at one or more of these sites (Fig. 1C) . In addition, two-dimensional-based detection of full-length versus GzmB-truncated ␣-tubulin suggested that GzmB proteolysis generated a fragment with a substantially more basic isoelectric point than the full-length molecule (Fig. 1A) . As the C-terminal tail of ␣-tubulin is highly enriched in acidic amino acids, removal of this region would generate a substantially more basic proteolytic fragment. Two amino acids (Asp 431 and Asp 438 ) within the ␣-tubulin tail therefore represented the most likely GzmB cleavage sites (Fig. 4A) . Of particular interest, one of these motifs, VGVD2SV highly resembled many previously identified GzmB cleavage sites, with a valine residue in the predicted P4 position and a highly conserved serine residue in the P1Ј position that has been identified to play an important role in determining the extended substrate specificity of this granzyme (Fig. 4B) (10, 13) . To identify the GzmB cleavage site, we used site-directed mutagenesis to change both candidate P1 aspartate residues to alanine. We then examined the ability of GzmB to cleave in vitro translated versions of these proteins. As shown in Fig. 4C , whereas the D431A mutant was cleaved as readily as wild-type ␣-tubulin, the D438A mutant was profoundly resistant to GzmB proteolysis. Thus, GzmB cleaves ␣-tubulin at a single canonical cleavage site (Asp 438 ). We next asked whether caspases also cleave ␣-tubulin at this site, by adding the in vitro translated proteins into Jurkat cell-free extracts supplemented with cytochrome c/dATP. As shown in Fig. 4D , whereas the D431A mutant was cleaved by caspases, the D438A mutant resisted proteolysis. Therefore, both GzmB and caspases target ␣-tubulin at the same cleavage site. Inspection of the acidic tail of ␣-tubulin from several mammalian species revealed complete conservation of the GzmB/ caspase cleavage site (Fig. 4E) . Moreover, alignment of all the human ␣-tubulin isoforms revealed that this site was present in all ␣-tubulin isoforms except ␣-tubulin-4 (Fig. 4F) .
GzmB Enhances Microtubule Polymerization-␣-Tubulin can be demarcated into several distinct domains, including the GTP binding motif in the N terminus and the acidic C-terminal tail (Fig. 4A) . Interestingly, many studies have implicated the tubulin tail as a critical regulator of microtubule polymerization/aggregation (25, 26) . This is utilized in vivo by MAPs (microtubule-associated proteins) such as tau and MAP that bind to the tubulin tail to regulate microtubule polymerization dynamics (27, 28) . Because GzmB cleavage removes the C-terminal 13 amino acids of the ␣-tubulin tail, we were interested to determine what effect this might have on microtubule polymerization. To explore this, we used highly purified bovine ␣-and ␤-tubulin that can be induced to form microtubules in vitro upon addition of GTP. Microtubule polymerization in vitro can be measured as an increase in absorbance at 340 nm (25) (26) (27) . To analyze the effects of GzmB in this system, we preincubated unpolymerized tubulin with GzmB to facilitate tubulin proteolysis, after which GTP was added to stimulate microtubule polymerization. Because the GzmB cleavage site is conserved in bovine ␣-tubulin, we readily detected cleavage of the latter by GzmB (Fig. 5) . As shown in Fig. 5A , the kinetics of microtubule polymerization was dramatically enhanced in the GzmB-treated reaction compared with a mock-incubated buffer-alone control. Indeed, concentrations as low as ϳ30 nM GzmB enhanced microtubule polymerization rates under reaction conditions where tubulins were present at Ͼ1000-fold molar excess compared with GzmB (Fig. 5B) . These data suggest that GzmBmediated removal of the acidic tail of ␣-tubulin dramatically alters the propensity of microtubules to form.
Enhanced Microtubule Polymerization during GzmB-mediated Killing-To examine the effects of GzmB cleavage of ␣-tubulin in vivo, we loaded HeLa cells with GzmB using low doses of the bacterial poreforming toxin, SLO. As shown in Fig. 6A , exposure of HeLa cells to GzmB/SLO rapidly induced apoptosis in the majority of these cells within 3.5 h. Because cells undergoing GzmB-mediated apoptosis rapidly detached from the substratum, we included the caspase inhibitor Z-VAD-fmk (100 M) to delay cell detachment and other caspase-dependent features of apoptosis. As shown in Fig. 6A , inclusion of Z-VADfmk blocked the induction of apoptosis in the HeLa cells, enabling us to exclude caspase-dependent effects on microtubules. To visualize microtubules, cells treated with GzmB/SLO for 7 h were fixed and immunostained with the ␣-tubulin-specific monoclonal antibody DM1A. As shown in Fig. 6 , B and C, in cells treated with SLO alone or GzmB in the absence of SLO, the microtubule network appeared normal and was composed of fine filamentous tubules. In sharp contrast, many of the cells treated with GzmB/SLO exhibited abnormal microtubules that appeared noticeably thicker and longer than in untreated cells (Fig. 6, B and C) . Note that inclusion of Z-VAD-fmk made it easier to visualize the changes to microtubule networks as this blocked rounding and detachment of cells due to caspase activation. These aberrant microtubules were particularly obvious where they projected into foci at the edges of the cells (Fig. 6C ). Taken together with the in vitro data, these data suggest that GzmB-catalyzed removal of the ␣-tubulin tail perturbs normal microtubule networks and that this may contribute to the inactivation of target cells during CTL/NK-mediated killing.
Role of ␣-Tubulin in Apoptosis-We next investigated whether manipulation of cellular ␣-tubulin levels could influence sensitivity to apoptosis. To this end, we designed two siRNA oligos to down-regulate ␣-tubulin expression (see "Experimental Procedures"). Based on sequence conservation, these siRNAs were designed to match the K-␣1 and ␣-6 isoforms of ␣-tubulin, which represent the most abundant ␣-tubulin isoforms expressed in HeLa cells (29, 30) . It should be noted, however, that these siRNAs exhibited sequence mismatches toward other ␣-tubulin isoforms, including ␣-tubulin-2 and ␣-tubulin-8, and may not silence expression of these isoforms.
As shown in Fig. 7A , transfection of HeLa cells with either siRNA achieved a significant, but incomplete, down-regulation of ␣-tubulin. Down-regulation of ␣-tubulin induced apoptosis in 25-30% of cells, whereas a control siRNA did not elicit this effect (Fig. 7B) . This is consistent with the known ability of microtubule-disrupting drugs such as vinblastine and vincristine to promote apoptosis. Moreover, transfection with ␣-tubulin siRNA also increased the frequency of mitotic cells in the cultures (Fig. 7C) , which is not unexpected given that tubulin is required to form the spindle apparatus essential for sister chromatid separation during mitosis.
We also asked whether siRNA-mediated silencing of ␣-tubulin in HeLa cells increased their susceptibility to YT-mediated killing. However, as shown in Fig. 7D , this treatment did not enhance NK-mediated killing above the levels seen using control oligos. This result is compatible with the view that CTL/NK cells most likely utilize multiple parallel strategies (via cleavage of Bid, caspases, and perhaps other substrates) to disable target cells and that disruption of microtubule networks is only one component of the CTL/NK killing process. Notwithstanding this, we were interested to determine whether expression of a non-cleavable (D438A) ␣-tubulin mutant could alter the kinetics or morphology of YT-mediated killing. However, as shown in supplemental Fig. S1 , expression of non-cleavable ␣-tubulin elicited little or no impact upon cell death induced by NK cells or by the cytotoxic drug actinomycin D. However, it is important to note that we were unable to detect overexpression of either wild-type ␣-tubulin or of the ␣-tubulin point mutants in HeLa cells. This is most likely because of the very high levels of endogenous ␣-tubulin expressed in these and many other cells (30) . We also made similar observations using human embryonic kidney 293T cells (data not shown). We can readily rule out trivial reasons for the latter observations as all tubulin constructs were fully sequenced and were translatable using an in vitro transcription/translation system (see Fig. 4C ). Thus, we cannot formally exclude the possibility that the noncleavable ␣-tubulin mutant may interfere with the kinetics or phenotype of apoptosis under circumstances where sufficient amounts of this protein can be expressed to compete effectively with wild-type ␣-tubulin. Future investigations will explore this possibility.
DISCUSSION
The present study demonstrates that severing of microtubules by GzmB-dependent or caspase-dependent proteolysis is characteristic of apoptosis induced by CTL/NK attack as well as by other triggers of cell death. Whereas both ␣-and ␤-tubulin subunits were readily processed by caspases, GzmB preferentially hydrolyzed ␣-tubulin and did not cleave ␤-tubulin. We also show that cleavage of microtubules by GzmB dramatically enhanced their polymerization rates and led to aberrant microtubule networks. Therefore, proteolysis of tubulin by GzmB is likely to impair microtubule function during CTL/NK-mediated killing.
It has long been established that the microtubule network fulfills numerous critical biological roles. These include, but are not restricted to, coordinating sister chromosome separation during mitosis, transporting of vesicles and organelles, and regulating cell motility (31, 32) . In addition, many viruses exploit the host microtubule network upon entry into host cells (33) . In light of these diverse biological roles, it is not surprising that pharmacological interference with microtubule stability has been successfully exploited as an important chemotherapeutic strategy (32) . As well as inhibiting mitosis of tumor cells, microtubule poisons also trigger apoptosis in many contexts (34) .
Here we have found that both GzmB and caspases cleave a site within the ␣-tubulin C terminus. In this context, it is interesting to note that previous studies have highlighted a critical role for this disordered and highly acidic region as a regulator of microtubule polymerization dynamics (25, 26, 35) . In agreement with our observations using GzmB, studies using the Bacillus subtilis protease subtilisin have demonstrated that removal of the C-terminal tail from ␣-and ␤-tubulin dramatically enhances the propensity of microtubules to polymerize (25, 26) .
Several studies have identified a motif (Glu 447 -Gly-Glu-Glu 450 ) within the extreme C terminus of tubulin as being responsible for binding to MAPs such as MAP2, tau, and Dynein (27, 28) . MAPs can be subdivided into two biological categories: MAP2 and tau regulate tubulin polymerization, whereas dynein and other molecular motors facilitate cargo transport (32) . Proteolytic removal of the tubulin C terminus by subtilisin digestion renders tubulin insensitive to binding of MAP proteins and impairs dynein and kinesin activity in vitro (28, 36, 37) . Here we have identified that endogenous proteases can proteolytically remove the MAP binding region within tubulin during apoptosis. This would predictably have severe consequences for the regulation of microtubule function, causing deregulated microtubule polymerization dynamics (Figs. 5 and 6) or abrogating microtubule-dependent motor protein activity.
In light of their important biological roles, it is interesting and perhaps predictable that microtubules constitute targets of cell death-associated caspases and of GzmB. Severing of microtubules represents a novel biological function for GzmB during NK/CTL killing and may complement additional GzmB-dependent killing mechanisms (via Bid and caspases) to limit the mitotic potential of tumor cells. Alternatively, because microtubules are known to be exploited by viruses for entry as well as exit from the host cell, it is possible that disruption of microtubule function by GzmB may help to rapidly terminate virion production in infected target cells.
